Teva-Betamethasone/Calcipotriol · DIN 02427419 · 50 mcg/g & 0.5 mg/g · Oint
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Teva-Betamethasone/Calcipotriol · DIN 02427419
Manufacturer: Teva Canada Limited; listing date 2021-04-30
Health Canada: Marketed since 2020-08-07 · brand TEVA-BETAMETHASONE/ CALCIPOTRIOL · ATC D07XC01 BETAMETHASONE · form Ointment · route Topical · ingredients BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG/G, CALCIPOTRIOL 50 MCG/G · company Teva canada limited · schedule Prescription
Teva-Betamethasone/Calcipotriol: Formulary list price $1.25 per unit (the source does not state the unit; exact figure $1.2545). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02427419)
Source record
DIN 02427419: Teva-Betamethasone/Calcipotriol
Raw flags: sec3=Y
Item: 840600151; group id 840; item number 2043; lccId None; manufacturer id TEV
Source form: Oint; strength: 50mcg/g & 0.5mg/g
Recorded listing: General benefit
Source prices (unrounded): $1.2545; ministry $1.2545
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02427419
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=91194
Therapeutic Notes (formulary)
Note: For use in patients with psoriasis who have failed 1st line topical steroids and Dovonex (calcipotriol) therapy.
Interchangeable products
Dovobet · DIN 02244126 · $1.2545
Shortage status: not checked (no credentials)